Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fletcher

Showing results (571-580 of 701) with videos related to

Pageof 71
Sort By:
Oncogene|December 14, 2018
STAT3 inhibition reduces macrophage number and tumor growth in neurofibromaJonathan S Fletcher, Mitchell G Springer, Kwangmin Choi, et al.
Transfusion|May 3, 2020
A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an optionMarc Zumberg, Jed Gorlin, Elizabeth A Griffiths, et al.
Cancer Treatment Reports|November 1, 1979
DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristineG J Hill, G E Metter, E T Krementz, et al.
Cancer|November 15, 1986
A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomasJ H Saiki, L H Baker, S E Rivkin, et al.
Cell|May 19, 1995
Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthaseJ D MacMicking, C Nathan, G Hom, et al.
Journal of Surgical Oncology|January 1, 1976
A randomized pilot study comparing two regimens in the treatment of squamous cell carcinomaH S Moseley, T Sasaki, D B McConnell, et al.
Journal of Surgical Oncology|January 1, 1979
5-FU versus combination therapy with tubercidin, streptozotocin, and 5-FU in the treatment of pancreatic carcinomas: COG protocol 7230A Awrich, W S Fletcher, J H Klotz, et al.
International Journal of Psychiatry in Medicine|April 24, 2021
FACT effectiveness in primary care; a single visit RCT for depressive symptomsB Arroll, H Frischtak, R Roskvist, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2000
Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouseC J Mann, K Honeyman, A J Cheng, et al.
Cancer|August 27, 1999
Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trialC G Leichman, J R Jacobson, M Modiano, et al.
Pageof 71

Showing results (571-580 of 701) with videos related to

Sort By:
Pageof 71
Oncogene|December 14, 2018
STAT3 inhibition reduces macrophage number and tumor growth in neurofibromaJonathan S Fletcher, Mitchell G Springer, Kwangmin Choi, et al.
Transfusion|May 3, 2020
A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an optionMarc Zumberg, Jed Gorlin, Elizabeth A Griffiths, et al.
Cancer Treatment Reports|November 1, 1979
DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristineG J Hill, G E Metter, E T Krementz, et al.
Cancer|November 15, 1986
A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomasJ H Saiki, L H Baker, S E Rivkin, et al.
Cell|May 19, 1995
Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthaseJ D MacMicking, C Nathan, G Hom, et al.
Journal of Surgical Oncology|January 1, 1976
A randomized pilot study comparing two regimens in the treatment of squamous cell carcinomaH S Moseley, T Sasaki, D B McConnell, et al.
Journal of Surgical Oncology|January 1, 1979
5-FU versus combination therapy with tubercidin, streptozotocin, and 5-FU in the treatment of pancreatic carcinomas: COG protocol 7230A Awrich, W S Fletcher, J H Klotz, et al.
International Journal of Psychiatry in Medicine|April 24, 2021
FACT effectiveness in primary care; a single visit RCT for depressive symptomsB Arroll, H Frischtak, R Roskvist, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2000
Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouseC J Mann, K Honeyman, A J Cheng, et al.
Cancer|August 27, 1999
Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trialC G Leichman, J R Jacobson, M Modiano, et al.
Pageof 71